| Product Name | MF | CAS | Details |
|---|
| R-Pantoprazole | C16H15F2N3O4S | 142706-18-1 | Details |
| Desfluoro Rosuvastatin Sodium Salt | C22H29N3O6S | 847849-66-5 | Details |
| Sildenafil Impurity 3 | C23H32N6O4S | 642928-07-2 | Details |
| Fulvestrant Impurity I | C17H20N4O5S | 1357931-55-5 | Details |
| Sildenafil EP Impurity F | C21H28N6O4S | 139755-82-1 | Details |
| Valsartan Methyl Ester | C22H30N6O5S | 1094598-75-0 | Details |
| Valsartan Methyl Ester | C29H32N6O9 | 1365267-35-1 | Details |
| Tofacitinib Impurity FD+DX | C19H17Cl2N3O5S | 1770812-37-7 | Details |
| Phthalamic Acid | C38H46N10O8S2 | 1346602-67-2 | Details |
| Fulvestrant Impurity I | C19H19N3O5S | 1415566-28-7 | Details |
| 1,3-dimethyl-56-nitrosourea | C20H26N6O4S | 139755-91-2 | Details |
| Nintedanib Impurity 60 | C39H60N10O20P2 | 1093279-76-5 | Details |
| Tenofovir impurity I (Mixture of Diastereomers) | C21H34N5O9P | 1246812-23-6 | Details |
| Tenofovir Alafenamide Impurity 26 | C18H23N6O5P | 1234081-04-9 | Details |
| Tenofovir Alafenamide Impurity 34 | C18H24N5O4P | 2126010-05-5 | Details |
| Tenofovir impurity H (Mixture of Diastereomers) | C19H30N5O10P | 1280130-08-6 | Details |
| tenofovir alafenamide Impurity 1 | C21H36N7O6P | 1883563-86-7 | Details |
| Sitagliptin Impurity 15 | C15H18F3NO4 | 486460-00-8 | Details |
| Tenofovir impurity 87 | C13H22N5O4P | 180587-75-1 | Details |
| Tadalafil EP impurity H | C22H19N3O6 | 1978322-98-3 | Details |
| Tadalafil EP impurity A | C22H19N3O4 | 171596-27-3 | Details |
| Tenofovir impurity | C8H11N5O | 14047-27-9 | Details |
| Cilnidipine Impurity 14 | C9H14N5O4P | 147127-20-6 | Details |
| Rosuvastatin EP Impurity A | C18H28N5O9P | 1610043-62-4 | Details |
| C9H14N5O4P | Details |
| Baricitinib Impurity I | C21H22N5O4P | 342631-41-8 | Details |
| Rosuvastatin EP Impurity A | C15H25N6O5P | 851456-00-3 | Details |
| Varenicline Impurity D | C15H18N5O4P | 379270-35-6 | Details |
| Noradrenaline Impurity 25 | C23H36N5O12P | 1244022-54-5 | Details |
| Roflumilast Impurity D | C11H12O4 | 1243391-44-7 | Details |
| Roflumilast Impurity C | C5H4Cl2N2 | 22889-78-7 | Details |
| Roflumilast Impurity I | C17H14Cl2F2N2O4 | 292135-78-5 | Details |
| Roflumilast Impurity H | C14H8Cl2F4N2O3 | 162401-30-1 | Details |
| Roflumilast Impurity A | C17H14Cl2F2N2O3 | 162401-43-6 | Details |
| Roflumilast Impurity B | C16H14Cl2N2O3 | 475271-62-6 | Details |
| Rivaroxaban iMpurity 6 | C19H18ClN3O5S | 865479-71-6 | Details |
| Cilnidipine Impurity 51 | C16H19N3O5 | 1429334-00-8 | Details |
| Nintedanib Impurity 39 | C36H36N6O10 | 1365267-36-2 | Details |
| Rivaroxaban iMpurity 5 | C22H19N3O6 | 446292-08-6 | Details |
| 1,3-dimethyl-11-nitrosourea | C25H24Cl2N4O6S2 | 1187188-59-6 | Details |
| Rivaroxaban iMpurity 10 | C24H21Cl2N3O7S2 | 1151893-81-0 | Details |
| Nintedanib Impurity 72 | C38H36Cl2N6O10S2 | 1632463-24-1 | Details |
| S-Clopidogrel N-Methyl Impurity | C16H18ClNO2S | 1346605-15-9 | Details |
| R-Clopidogrel Carboxylic Acid | C15H14ClNO2S | 324757-50-8 | Details |
| Sitagliptin IMpurity 18 | C16H12F6N4O2 | 764667-65-4 | Details |
| Tenofovir Impurity 120 | C11H18N5O4P | 1255525-18-8 | Details |
| RaMelteon iMpurity F | C16H21NO2 | 196597-17-8 | Details |
| RaMelteon iMpurity H | C11H10Br2O3 | 196597-76-9 | Details |
| RaMelteon iMpurity I | C11H8Br2O2 | 196597-77-0 | Details |
| RaMelteon iMpurity G | C13H18O2 | 51146-56-6 | Details |
| Sitagliptin Impurity 11 | C15H20FNO4 | 218609-00-8 | Details |
| Sitagliptin Impurity 10 | C15H20FNO4 | 331763-66-7 | Details |
| Sitagliptin Impurity 17 | C15H18F3NO4 | 922178-94-7 | Details |
| Sitagliptin IMpurity 7 | C15H19F2NO4 | 851307-12-5 | Details |
| (R)-3-((tert-butoxycarbonyl)amino) | C15H19F2NO4 | 486459-98-7 | Details |
| Solifenacin EP impurity C | C31H28N2O | 1534326-81-2 | Details |
| Solifenacin EP impurity A | C15H15N | 118864-75-8 | Details |
| Solifenacin Related Compound 6 | C15H13N | 52250-50-7 | Details |
| Solifenacin EP Impurity I | C23H26N2O3 | 180272-28-0 | Details |
| Solifenacin EP impurity H | C27H32N2O6 | 862207-71-4 | Details |
| Solifenacin Related Compound 8 | C18H19NO2 | 180468-42-2 | Details |
| Solifenacin Related Compound 10 | C25H30N2O2 | 605696-10-4 | Details |
| Sildenafil Impurity 1 | C17H20N4O2 | 139756-21-1 | Details |
| Sildenafil Impurity 2 | C17H19ClN4O4S | 139756-22-2 | Details |
| Sitagliptin EP Impurity C | C16H16F5N5O | 945261-48-3 | Details |
| Sitagliptin EP Impurity B | C16H16F5N5O | 486460-31-5 | Details |
| Sitagliptin EP Impurity M | C15H20FNO4 | 218608-98-1 | Details |
| Sitagliptin EP Impurity A(Phosphate) | C16H16F6N5O5P | 823817-58-9 | Details |
| Sitagliptin EP Impurity G | C15H19F2NO4 | 269396-59-0 | Details |
| Rosuvastatin Impurity | C20H24FN3O5S | Details |
| Rosuvastatin Impurity | C22H28FN3O6S | 1584149-34-7 | Details |
| (R)-methyl 3-((tert-butoxycarbonyl) | C16H20F3NO4 | 881995-73-9 | Details |
| Tofacitinib Impurity FD+DX | C11H12F3NO2 | 881995-69-3 | Details |
| Sitagliptin Impurity 23 | C16H16F6N5O4P | 1351498-25-3 | Details |
| Sitagliptin Impurity 21 | C16H13F6N5O | 847445-81-2 | Details |
| Sitagliptin Impurity 40 | C16H12F6N4O | 1675201-14-5 | Details |
| methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate | C11H9F3O3 | 769195-26-8 | Details |
| (S)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride | C10H11ClF3NO2 | 1217809-78-3 | Details |
| Sitagliptin Impurity 20 | C26H23F9N6O2 | 2072867-07-1 | Details |
| Sitagliptin Impurity 12 | C16H12F6N4O | 1803026-54-1 | Details |
| Sorafenib impurity V | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| Sorafenib impurity Y | C21H17F3N4O3 | 1285533-84-7 | Details |
| (R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)- | C21H23F6N5O3 | 486460-23-5 | Details |
| (E)-1-(3-(trifluoromethyl) | C16H12F6N4O | 1253056-18-6 | Details |
| Tenofovirdisoproxil ImpurityG | C18H28N5O10P | 1422284-16-9 | Details |
| 2-hydroxy-57-(methylthio)butanamide | C17H26N5O10P | 1246812-43-0 | Details |
| Solifenacin EP impurity E | C7H13NO | 25333-42-0 | Details |
| Solifenacin EP impurity B | C19H21NO2 | 1353274-25-5 | Details |
| Sorafenib impurity B | C7H7ClN2O | 845306-04-9 | Details |
| Sorafenib IMpurity G | C10H9ClF3NO2 | 18585-06-3 | Details |
| Sorafenib impurity O | C14H14N4O3 | 1129683-88-0 | Details |
| Sorafenib impurity N | C8H6ClF3N2O | 343247-69-8 | Details |
| Sorafenib impurity U | C27H24N6O5 | 284670-98-0 | Details |
| Sorafenib impurity D | C7H5ClF3N | 320-51-4 | Details |
| Regorafenib Impurity 20 | C15H8Cl2F6N2O | 370-50-3 | Details |
| Solifenacin EP impurity F | C27H32N2O6 | 1262506-09-1 | Details |
| Solifenacin EP impurity G | C27H32N2O6 | 862207-70-3 | Details |
| Sitagliptin EP Impurity D | C18H17F6N5O2 | 1379666-94-0 | Details |
| Tadalafil EP Impurity B ((6S,12S)-Tadalafil) | C22H19N3O4 | 629652-72-8 | Details |
| Tadalafil EP Impurity C ((6S,12R)-Tadalafil) | C22H19N3O4 | 171596-28-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 | ||||